Recent studies also demonstrate that USP22 plays a critical role in cancer immunosuppression through stabilizing FOXP3 activity in Treg [31] and programmed death-ligand 1 (PD-L1) in cancer [32, 33]. This evidence concerns the gene FOXP3 and cancer.